Psychedelics Awakn Life Sciences helps establish psychedelics clinics in Portugal Awakn will also be providing its clinical protocols and training to Portuguese clinicians in a 10-year agreement Rowan DunneFebruary 22, 2023
News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023
Psychedelics Awakn set to research ketamine for alcohol use disorder The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost Rowan DunneDecember 14, 2022
Psychedelics TripSitter acquires Reconscious Medical assets to enhance its treatment options TripSitter says the acquisition will be 'instrumental' for the future of the company Rowan DunneNovember 14, 2022
Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
International Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period Rowan DunneOctober 20, 2022
News ASKP3 Patient Portal to offer accurate fact-based info on ketamine Platform is intended to educate patients and medical providers on benefits of ketamine for treating pain and mood disorders Rowan DunneOctober 14, 2022
Psychedelics Choose Ketamine now offering at-home treatments in several states Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost Rowan DunneOctober 4, 2022
Psychedelics Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation Company will collaborate with Premier Consulting as regulatory partner and utilize Zylö Therapeutics Z-Pod technology Rowan DunneOctober 3, 2022